The phenomenon of "forced normalization" in the framework of psychotic changes in epileptic patients
Pylaeva, O.A.; Voronkova, K.V.; Petrukhin, A.S.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(7): 72-74
2004
ISSN/ISBN: 1997-7298 PMID: 15347039 Document Number: 570615
Document emailed within 1 workday
Related Documents
Friis, S. 1981: What kind of ward atmosphere is therapeutic for psychotic and non-psychotic patients? Necessity of differentiated treatment milieus Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 101(14): 848-852Chu, N.S. 1988: Long-term ambulatory EEG evaluation of epileptic seizures and non-epileptic attacks: a study of 100 patients Zhonghua Yi Xue Za Zhi 42(5): 359-366
Ando, K.; Hironaka, N.; Yanagita, T. 1986: Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence Psychopharmacology Bulletin 22(3): 763-767
Tischler, S. 1979: Being with a psychotic child a psycho-analytical approach to the problems of parents of psychotic children International Journal of Psycho-Analysis 60(1): 29-38
Pérez Rasgado, S.; Wamba Magallanes, F.; Gómez Gil, R. 1977: Psychotic and non psychotic organic brain syndromes in the psychiatric service of a general hospital Archivos de Neurobiologia 40(2): 53-78
Ching, B.; Horsfall, P.A. 1978: Nomograms for forced expiratory volume and forced vital capacity in normal Cantonese subjects Modern Medicine of Asia 14(8): 47-49
Sijuwola, O.A. 1987: Psychotic and non-psychotic temporal lobe epileptics East African Medical Journal 64(8): 538-542
Nakadate, T. 1997: Age-related decline in forced expiratory volume in one second and forced vital capacity based on a longitudinal observation of Japanese males Nihon Kyobu Shikkan Gakkai Zasshi 35(9): 954-959
Klimov, A.N.; Nikulchev, N.G. 1973: Various pharmacological approaches to normalization of lipid metabolism in patients with arteriosclerosis Terapevticheskii Arkhiv 45(6): 29-33
Zelins'kyĭ, B.O.; Palamarchuk, A.V. 1996: Antioxidant system disorder in diabetic patients and the means for its normalization Likars'ka Sprava 1996(7-9): 99-102
Czernikiewicz, A.; Szulc, A. 2007: Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part I. Clinical identification of pre-psychotic states Psychiatria Polska 41(1): 5-15
Kashiwazaki, D.; Kuroda, S.; Ushikoshi, S.; Shichinohe, H.; Ishikawa, T.; Asano, T.; Shiga, T.; Tamaki, N.; Iwasaki, Y. 2003: Normalization of cerebral hemodynamics and metabolism after carotid stenting in patients unfit for major surgery No Shinkei Geka. Neurological Surgery 31(12): 1315-1320
Wechapinan, T.; Sri-Udomkajorn, S.; Suwannachote, S. 2014: Rare epileptic syndrome of ring chromosome 20 with epileptic encephalopathy: a case report Journal of the Medical Association of Thailand 97 Suppl. 6: S239-S242
Marchant, N.F.; Sánchez de López, L.; Lillo, L. 1987: Psychodrama in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(4): 326-331
Neuhäuser, G. 1982: Seizure syndromes in childhood. Diagnosis and therapy of epileptic and non-epileptic seizures Die Medizinische Welt 33(40): 1384-1389
De Romanis, F.; Sopranzi, N. 1990: Bombesin, dermorphin, physalaemin and sauvagine: effects on superficial and depth EEG tracings in epileptic and non-epileptic rats La Clinica Terapeutica 133(1): 35-38
Ricci, C.; Minetto, E.; Cascio, G.; De Stefano, A.; Basso, M.; Borelli, P.; Bozzone, D.; Delia, D.; Baldassi, R. 1984: Normalization of electrophoretic mobility of lymphocytes in patients with primary immunoglobulin deficiency treated with intravenous immunoglobulins Acta Medica Hungarica 41(4): 297-302
Cabral, C.A.; Gracía, D. 1977: Psychodramatic experiences with psychotic patients Acta Psiquiatrica y Psicologica de America Latina 23(1): 44-49
Lagomarsino, A.J. 1987: Haloperidol decanoate in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
Schmalbach, K.; Helmke, K.; Heinen, D.; Müller, S.; Suchatzki, B.U. 1973: Moxisylyt as a therapeutic agent in epileptic disturbances. Experimental study on normal cats and animals with chronic epileptic processes Arzneimittel-Forschung 23(12): 1734-1737